Conversations in CNS: Expert Notes from the Field on Trial Success
Despite exciting recent approvals of mechanistically novel CNS drugs, the reality remains: CNS clinical trials face uniquely challenging obstacles that can lead to failures, even when early results look promising.
Why do early successes often fail to replicate in larger trials? What separates the breakthrough CNS programs from the costly failures?
"Conversations in CNS: Expert Notes from the Field on Trial Success" reveals the answers through hard-won insights from veteran clinicians and scientists who've dedicated their careers to CNS research.
Written by Dr. David G. Daniel and our team, this isn't theoretical guidance—it's practical wisdom from over 30 years of psychiatric clinical trial experience, distilled into concrete strategies you can implement immediately.
